PharmaEngine Free Cash Flow Generation Index
PharmaEngine free cash flow generation index. PharmaEngine (4162) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of NT$52.90 Million represents 1% of operating cash flow (NT$53.01 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of PharmaEngine (2011–2024)
Free cash flow generation index of PharmaEngine from 2011 to 2024. Historical FCF Generation Index trend for PharmaEngine across 12 annual periods. See 4162 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
PharmaEngine Free Cash Flow Generation Index by Year (2011–2024)
PharmaEngine free cash flow generation index by year from 2011 to 2024. Year-by-year Free Cash Flow Generation Index for PharmaEngine. For the full cash flow conversion analysis, see PharmaEngine (4162) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | NT$455.32 Million | NT$456.73 Million | NT$1.42 Million | ▲ +0.1% |
| 2023 | 1.00x | NT$256.01 Million | NT$256.97 Million | NT$958.00K | ▲ +1.6% |
| 2022 | 0.98x | NT$198.07 Million | NT$202.01 Million | NT$3.94 Million | ▼ -1.9% |
| 2021 | 1.00x | NT$929.44 Million | NT$929.67 Million | NT$229.00K | ▲ +0.9% |
| 2020 | 0.99x | NT$64.16 Million | NT$64.77 Million | NT$608.00K | ▲ +0.4% |
| 2019 | 0.99x | NT$15.87 Million | NT$16.08 Million | NT$208.00K | ▼ -1.2% |
| 2018 | 1.00x | NT$744.72 Million | NT$745.23 Million | NT$510.00K | ▲ +0.1% |
| 2016 | 1.00x | NT$869.24 Million | NT$870.38 Million | NT$1.15 Million | ▲ +2.6% |
| 2015 | 0.97x | NT$436.19 Million | NT$447.99 Million | NT$11.80 Million | ▼ -2.6% |
| 2014 | 1.00x | NT$130.99 Million | NT$131.09 Million | NT$95.00K | ▲ +0.0% |
| 2012 | 1.00x | NT$68.56 Million | NT$68.64 Million | NT$83.00K | ▲ +0.2% |
| 2011 | 1.00x | NT$274.68 Million | NT$275.49 Million | NT$806.00K | — |